Eurican Herpes 205 Pulver und Lösungsmittel zur Herstellung einer Emulsion zur Injektion AND Purevax RCP – Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension für Katzen
Recall
|
Veterinary Medicines
|
08/03/2024
The marketing authorisation holder informed its customers on March 05, 2024, that during routine quality controls, a glass defect that is difficult to detect was found in parts of the supplied glass vials and sterility cannot be guaranteed. For this reason, the mentioned batches are being recalled as a precautionary measure. The risk of a possible health hazard for treated animals can be classified as insignificant.
| Name of the medicinal product | 1) Eurican Herpes 205 Pulver und Lösungsmittel zur Herstellung einer Emulsion zur Injektion 2) Purevax RCP – Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension für Katzen |
|---|---|
| Marketing authorisation number(s) | 1) EU/2/01/029/001-003 2) EU/2/04/052/001-002 |
| CIP code | 1) 2454426 2) 4989982 |
| Marketing authorisation holder | Boehringer Ingelheim RCV GmbH & Co KG |
| Batch number(s) | Batch, Expiry Date 1) F48157, 20.06.2025 2) F34064, 24.11.2024 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-4661 |
Further inquiry note
Page last modified:
08/03/2024